2024

Unveiling the New TRIPS Flexibilities Navigator

Health AI: A better-balanced narrative

Climate and health are inextricably linked

Introducing the Digital Rights and Health Alliance

AMR: Busy month, busy times to come

Addressing medicines shortages in the European Union

INB 9: Final opportunity for States to agree on pandemic treaty?

Enabling Access to Medical Innovations for all

2023

A strategic approach to snakebite community engagement

Lack of diagnostics helps fuel AMR

2022

Advancing family planning solutions in Burundi

Call for Action: High Time to Prioritise Health in the EU Artificial Intelligence Act

HAI is Hiring!

2021

Talking Medicine Pricing

Over 9 million people living with type 1 diabetes

European Commission is offering no meaningful solutions for equitable access

Clinical Trial Data and the Risk of Bias

Getting Hack to Reality

Health Action International successful recipients of core funding from the European AI Fund

2020

There is no UHC without Universal Medicines Coverage

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

What do the next five years have in store for the European Medicines Agency?

COVID-19 and Snakebite: Including the voices of our most marginalised

COVID-19 risks turning back the clock on years of essential development work

Reflections on the World Health Assembly

Europe’s Beating Cancer Plan

2019

Statement from the ACCISS Study regarding the WHO announcement of the first-ever insulin prequalification programme

Biased cancer drug trials are only good for one group…and it’s not patients

In Memory of Royjan Taylor

2018

HAI and Snakebite Programme Partner, James Ashe Antivenom Trust, Applaud Government Action on Antivenom at Bio-Ken Snakebite Symposium